{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:58:46Z","timestamp":1785466726303,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Liaoning Province Natural Science Foundation","doi-asserted-by":"crossref","award":["2024-MS-197"],"award-info":[{"award-number":["2024-MS-197"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2021-BS-268"],"award-info":[{"award-number":["2021-BS-268"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2021-BS-269"],"award-info":[{"award-number":["2021-BS-269"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12479-2","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T08:34:53Z","timestamp":1785141293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Paeoniflorin attenuates cardiac remodeling by targeting AKT1 and suppressing the AKT\/NF-\u03baB inflammatory axis"],"prefix":"10.1007","volume":"53","author":[{"given":"Haiyan","family":"Luan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0260-1411","authenticated-orcid":false,"given":"Xingyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"supplO","key":"12479_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/eurheartj\/16.suppl_o.107","volume":"16","author":"CG Brilla","year":"1995","unstructured":"Brilla CG et al (1995) The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure. Eur Heart J 16(supplO):107\u2013109. https:\/\/doi.org\/10.1093\/eurheartj\/16.suppl_o.107","journal-title":"Eur Heart J"},{"key":"12479_CR2","doi-asserted-by":"publisher","first-page":"1501330","DOI":"10.3389\/fphar.2025.1501330","volume":"16","author":"BJ Yan","year":"2025","unstructured":"Yan BJ et al (2025) Analysis of research trends and development prospects of soluble guanylate cyclase stimulators\/activators: using bibliometric methods. Front Pharmacol 16:1501330. https:\/\/doi.org\/10.3389\/fphar.2025.1501330","journal-title":"Front Pharmacol"},{"key":"12479_CR3","doi-asserted-by":"publisher","first-page":"155250","DOI":"10.1016\/j.phymed.2023.155250","volume":"125","author":"J Zhang","year":"2024","unstructured":"Zhang J et al (2024) Astragaloside IV mitigates hypoxia-induced cardiac hypertrophy through calpain-1-mediated mTOR activation. Phytomedicine 125:155250. https:\/\/doi.org\/10.1016\/j.phymed.2023.155250","journal-title":"Phytomedicine"},{"key":"12479_CR4","doi-asserted-by":"publisher","first-page":"107452","DOI":"10.1016\/j.pharmthera.2019.107452","volume":"207","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wei W (2020) Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol Ther 207:107452. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107452","journal-title":"Pharmacol Ther"},{"issue":"2","key":"12479_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41401-021-00671-y","volume":"43","author":"YF Liu","year":"2022","unstructured":"Liu YF et al (2022) Paeoniflorin ameliorates ischemic injury in rat brain via inhibiting cytochrome c\/caspase3\/HDAC4 pathway. Acta Pharmacol Sin 43(2):273\u2013284. https:\/\/doi.org\/10.1038\/s41401-021-00671-y","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"12479_CR6","doi-asserted-by":"publisher","first-page":"8678267","DOI":"10.1155\/2018\/8678267","volume":"2018","author":"Z Wen","year":"2018","unstructured":"Wen Z et al (2018) 6\u2032\u2010O\u2010Galloylpaeoniflorin Attenuates Cerebral Ischemia Reperfusion\u2010Induced Neuroinflammation and Oxidative Stress via PI3K\/Akt\/Nrf2 Activation. Oxidative Med Cell Longev 2018(1):8678267. https:\/\/doi.org\/10.1155\/2018\/8678267","journal-title":"Oxidative Med Cell Longev"},{"key":"12479_CR7","doi-asserted-by":"publisher","first-page":"614024","DOI":"10.3389\/fphar.2020.614024","volume":"11","author":"XT Wang","year":"2020","unstructured":"Wang XT et al (2020) Paeoniflorin and Hydroxysafflor Yellow A in Xuebijing Injection Attenuate Sepsis-Induced Cardiac Dysfunction and Inhibit Proinflammatory Cytokine Production. Front Pharmacol 11:614024. https:\/\/doi.org\/10.3389\/fphar.2020.614024","journal-title":"Front Pharmacol"},{"issue":"3","key":"12479_CR8","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s12010-021-03680-z","volume":"194","author":"H Ma","year":"2022","unstructured":"Ma H et al (2022) Peoniflorin Preconditioning Protects Against Myocardial Ischemia\/Reperfusion Injury Through Inhibiting Myocardial Apoptosis: RISK Pathway Involved. Appl Biochem Biotechnol 194(3):1149\u20131165. https:\/\/doi.org\/10.1007\/s12010-021-03680-z","journal-title":"Appl Biochem Biotechnol"},{"issue":"2","key":"12479_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1684\/ejd.2016.2946","volume":"27","author":"C Yu","year":"2017","unstructured":"Yu C et al (2017) Efficacy and safety of total glucosides of paeony combined with acitretin in the treatment of moderate-to-severe plaque psoriasis: a double-blind, randomised, placebo-controlled trial. Eur J Dermatol 27(2):150\u2013154. https:\/\/doi.org\/10.1684\/ejd.2016.2946","journal-title":"Eur J Dermatol"},{"key":"12479_CR10","doi-asserted-by":"publisher","first-page":"1072007","DOI":"10.3389\/fimmu.2022.1072007","volume":"13","author":"W Yu","year":"2022","unstructured":"Yu W et al (2022) Therapeutic potential of paeoniflorin in atherosclerosis: A cellular action and mechanism-based perspective. Front Immunol 13:1072007. https:\/\/doi.org\/10.3389\/fimmu.2022.1072007","journal-title":"Front Immunol"},{"key":"12479_CR11","doi-asserted-by":"publisher","first-page":"650278","DOI":"10.3389\/fcvm.2021.650278","volume":"8","author":"Z Li","year":"2021","unstructured":"Li Z, Zhao H, Wang J (2021) Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities. Front Cardiovasc Med 8:650278. https:\/\/doi.org\/10.3389\/fcvm.2021.650278","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"12479_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jacbts.2021.08.006","volume":"7","author":"MB Olsen","year":"2022","unstructured":"Olsen MB et al (2022) Targeting the Inflammasome in Cardiovascular Disease. JACC Basic Transl Sci 7(1):84\u201398. https:\/\/doi.org\/10.1016\/j.jacbts.2021.08.006","journal-title":"JACC Basic Transl Sci"},{"key":"12479_CR13","doi-asserted-by":"publisher","first-page":"155464","DOI":"10.1016\/j.phymed.2024.155464","volume":"128","author":"P Tuo","year":"2024","unstructured":"Tuo P et al (2024) Lycorine inhibits Ang II-induced heart remodeling and inflammation by suppressing the PI3K-AKT\/NF-\u03baB pathway. Phytomedicine 128:155464. https:\/\/doi.org\/10.1016\/j.phymed.2024.155464","journal-title":"Phytomedicine"},{"issue":"1","key":"12479_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1600-065X.2012.01098.x","volume":"246","author":"N Kanarek","year":"2012","unstructured":"Kanarek N, Ben-Neriah Y (2012) Regulation of NF-\u03baB by ubiquitination and degradation of the I\u03baBs. Immunol Rev 246(1):77\u201394. https:\/\/doi.org\/10.1111\/j.1600-065X.2012.01098.x","journal-title":"Immunol Rev"},{"issue":"2","key":"12479_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1023\/a:1011457910659","volume":"6","author":"A Matsumori","year":"2001","unstructured":"Matsumori A, Sasayama S (2001) The role of inflammatory mediators in the failing heart: immunomodulation of cytokines in experimental models of heart failure. Heart Fail Rev 6(2):129\u2013136. https:\/\/doi.org\/10.1023\/a:1011457910659","journal-title":"Heart Fail Rev"},{"key":"12479_CR16","doi-asserted-by":"publisher","unstructured":"Sun B et al (2013) Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy. Hypertension 61(2):352\u2009\u2013\u200960. https:\/\/doi.org\/10.1161\/hypertensionaha.111.00562","DOI":"10.1161\/hypertensionaha.111.00562"},{"key":"12479_CR17","doi-asserted-by":"publisher","unstructured":"Landel I, Mueller MP, Rauh D (2021) Co-Crystal Structure of Akt1 in Complex with Covalent-Allosteric Akt Inhibitor 3. Nature Communications 12(1):5297. https:\/\/doi.org\/10.1038\/s41467-021-25512-8","DOI":"10.1038\/s41467-021-25512-8"},{"issue":"8","key":"12479_CR18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/eurjhf\/hfr080","volume":"13","author":"AH Chaanine","year":"2011","unstructured":"Chaanine AH, Hajjar RJ (2011) AKT signalling in the failing heart. Eur J Heart Fail 13(8):825\u2013829. https:\/\/doi.org\/10.1093\/eurjhf\/hfr080","journal-title":"Eur J Heart Fail"},{"key":"12479_CR19","doi-asserted-by":"publisher","unstructured":"Araki S et al (2012) Akt1-mediated skeletal muscle growth attenuates cardiac dysfunction and remodeling after experimental myocardial infarction. Circ Heart Fail 5(1) 116\u2009\u2013\u200925. https:\/\/doi.org\/10.1161\/circheartfailure.111.964783","DOI":"10.1161\/circheartfailure.111.964783"},{"key":"12479_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.vph.2015.03.003","volume":"71","author":"H Yu","year":"2015","unstructured":"Yu H, Littlewood T, Bennett M (2015) Akt isoforms in vascular disease. Vascul Pharmacol 71:57\u201364. https:\/\/doi.org\/10.1016\/j.vph.2015.03.003","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"12479_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.yjmcc.2004.11.005","volume":"38","author":"T Matsui","year":"2005","unstructured":"Matsui T, Rosenzweig A (2005) Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol 38(1):63\u201371. https:\/\/doi.org\/10.1016\/j.yjmcc.2004.11.005","journal-title":"J Mol Cell Cardiol"},{"key":"12479_CR22","doi-asserted-by":"publisher","unstructured":"DeBosch B et al (2006) Akt1 is required for physiological cardiac growth. Circulation 113(17) 2097\u2009\u2013\u2009104. https:\/\/doi.org\/10.1161\/circulationaha.105.595231","DOI":"10.1161\/circulationaha.105.595231"},{"issue":"287","key":"12479_CR23","doi-asserted-by":"publisher","first-page":"ra67","DOI":"10.1126\/scisignal.2003948","volume":"6","author":"BA Kerr","year":"2013","unstructured":"Kerr BA et al (2013) Interference with akt signaling protects against myocardial infarction and death by limiting the consequences of oxidative stress. Sci Signal 6(287):ra67. https:\/\/doi.org\/10.1126\/scisignal.2003948","journal-title":"Sci Signal"},{"key":"12479_CR24","doi-asserted-by":"publisher","first-page":"113920","DOI":"10.1016\/j.jep.2021.113920","volume":"272","author":"Y Chen","year":"2021","unstructured":"Chen Y et al (2021) Pinoresinol diglucoside (PDG) attenuates cardiac hypertrophy via AKT\/mTOR\/NF-\u03baB signaling in pressure overload-induced rats. J Ethnopharmacol 272:113920. https:\/\/doi.org\/10.1016\/j.jep.2021.113920","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"12479_CR25","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1245\/s10434-016-5218-z","volume":"23","author":"P Malkomes","year":"2016","unstructured":"Malkomes P et al (2016) Selective AKT Inhibition by MK-2206 Represses Colorectal Cancer-Initiating Stem Cells. Ann Surg Oncol 23(9):2849\u20132857. https:\/\/doi.org\/10.1245\/s10434-016-5218-z","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"12479_CR26","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41419-018-0943-9","volume":"9","author":"L Sun","year":"2018","unstructured":"Sun L et al (2018) Ipatasertib, a novel Akt inhibitor, induces transcription factor FoxO3a and NF-\u03baB directly regulates PUMA-dependent apoptosis. Cell Death Dis 9(9):911. https:\/\/doi.org\/10.1038\/s41419-018-0943-9","journal-title":"Cell Death Dis"},{"issue":"1","key":"12479_CR27","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.intimp.2015.08.008","volume":"28","author":"N Xiang","year":"2015","unstructured":"Xiang N et al (2015) Total glucosides of paeony can reduce the hepatotoxicity caused by Methotrexate and Leflunomide combination treatment of active rheumatoid arthritis. Int Immunopharmacol 28(1):802\u2013807. https:\/\/doi.org\/10.1016\/j.intimp.2015.08.008","journal-title":"Int Immunopharmacol"},{"key":"12479_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1475-2840-10-4","volume":"10","author":"D Sun","year":"2011","unstructured":"Sun D et al (2011) Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3\u03b2 dependent pathway in experimental diabetic cardiomyopathy. Cardiovasc Diabetol 10:4. https:\/\/doi.org\/10.1186\/1475-2840-10-4","journal-title":"Cardiovasc Diabetol"},{"key":"12479_CR29","doi-asserted-by":"publisher","first-page":"110527","DOI":"10.1016\/j.intimp.2023.110527","volume":"122","author":"Z Fang","year":"2023","unstructured":"Fang Z et al (2023) Curcumol alleviates cardiac remodeling via the AKT\/NF-\u03baB pathway. Int Immunopharmacol 122:110527. https:\/\/doi.org\/10.1016\/j.intimp.2023.110527","journal-title":"Int Immunopharmacol"},{"key":"12479_CR30","doi-asserted-by":"publisher","first-page":"115275","DOI":"10.1016\/j.biopha.2023.115275","volume":"165","author":"E Ma","year":"2023","unstructured":"Ma E et al (2023) Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-\u03baB signaling. Biomed Pharmacother 165:115275. https:\/\/doi.org\/10.1016\/j.biopha.2023.115275","journal-title":"Biomed Pharmacother"},{"key":"12479_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.intimp.2018.01.049","volume":"57","author":"Y Liu","year":"2018","unstructured":"Liu Y et al (2018) Berberine inhibits macrophage M1 polarization via AKT1\/SOCS1\/NF-\u03baB signaling pathway to protect against DSS-induced colitis. Int Immunopharmacol 57:121\u2013131. https:\/\/doi.org\/10.1016\/j.intimp.2018.01.049","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"12479_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13020-021-00446-x","volume":"16","author":"J Chen","year":"2021","unstructured":"Chen J et al (2021) Potential mechanisms of Guizhi decoction against hypertension based on network pharmacology and Dahl salt-sensitive rat model. Chin Med 16(1):34. https:\/\/doi.org\/10.1186\/s13020-021-00446-x","journal-title":"Chin Med"},{"key":"12479_CR33","doi-asserted-by":"publisher","first-page":"p1642575","DOI":"10.1155\/2019\/1642575","volume":"2019","author":"J Zhang","year":"2019","unstructured":"Zhang J et al (2019) Antiapoptosis and Antifibrosis Effects of Qishen Granules on Heart Failure Rats via Hippo Pathway. Biomed Res Int 2019:p1642575. https:\/\/doi.org\/10.1155\/2019\/1642575","journal-title":"Biomed Res Int"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12479-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12479-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12479-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:04:42Z","timestamp":1785463482000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12479-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12479"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12479-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"23 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Acknowledgment section has been updated","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1271"}}